Leadership Overview
Pharmaron has 4 executives leading key functions including strategy, finance, technology, and revenue generation.
Driven by innovation, Pharmaron engages in discovery, development, and manufacturing for small molecule drugs, cell therapies, and gene therapies, alongside providing essential testing services for medical devices and clinical research.
Driven by innovation, Pharmaron engages in discovery, development, and manufacturing for small molecule drugs, cell therapies, and gene therapies, alongside providing essential testing services for medical devices and clinical research.
Leadership Roles at Pharmaron
Boliang Lou - Chairman & Chief Executive Officer
Boliang Lou, the Chairman & Chief Executive Officer at Pharmaron, directs the overarching strategy and operational execution across the company's comprehensive discovery, development, and manufacturing services. Overseeing the integration of small molecule drugs, cell therapies, and gene therapies, Lou ensures seamless progression from initial research to market-ready solutions. This leadership role involves guiding the company's expansion into testing services for medical devices and clinical research, aligning all functions with Pharmaron's mission to accelerate therapeutic innovation. By fostering a culture of scientific excellence and rigorous quality control, Boliang Lou drives the company's commitment to delivering high-value services to global partners. Lou's strategic vision shapes Pharmaron's market position and its capacity to address complex challenges in the life sciences sector.
Gilbert Li - Chief Financial Officer
Gilbert Li, the Chief Financial Officer at Pharmaron, manages all financial operations and strategic fiscal planning. Li oversees capital allocation, investment strategies, and financial reporting, ensuring robust economic health for the company's diverse service offerings, including discovery, development, and manufacturing for small molecule drugs, cell therapies, and gene therapies. This role is critical in supporting Pharmaron's expansion into medical device testing and clinical research services. By optimizing financial structures and managing risk, Gilbert Li enables sustained growth and operational efficiency across all business units. Li's expertise ensures Pharmaron maintains a strong financial foundation to support its global client base and its commitment to advancing therapeutic development.
Guangliang Pan - Senior Vice President and Chief Technology Officer, Biologics and Gene Therapy
Guangliang Pan, the Senior Vice President and Chief Technology Officer, Biologics and Gene Therapy at Pharmaron, spearheads technological innovation and development within the biologics and gene therapy sectors. Pan directs the advancement of cutting-edge platforms essential for the discovery, development, and manufacturing of these complex therapeutic modalities. This leadership position involves ensuring the integration of novel technologies to enhance Pharmaron's capabilities in cell and gene therapy services. By driving technological excellence, Guangliang Pan supports the company's mission to provide comprehensive solutions for its partners. Pan's focus on scientific rigor and technological foresight solidifies Pharmaron's position as a leader in advanced therapeutic development.
Pegah Jalili - Senior Account Manager & Chief Revenue Officer, Biologics, Cdmo
Pegah Jalili, the Senior Account Manager & Chief Revenue Officer, Biologics, Cdmo at Pharmaron, drives revenue growth and manages key client relationships within the biologics and contract development and manufacturing organization (CDMO) segments. Jalili oversees sales strategies and account management, ensuring alignment with Pharmaron's comprehensive service portfolio, which spans discovery, development, and manufacturing for small molecule drugs, cell therapies, and gene therapies. This role is pivotal in expanding market reach and securing new business opportunities. By fostering strong partnerships and understanding client needs, Pegah Jalili contributes directly to Pharmaron's commercial success and its mission to support therapeutic innovation. Jalili's leadership ensures sustained revenue generation and strengthens Pharmaron's market presence.
Explore Leadership Teams in Business Services
ICON was founded in 1990. This company provides drug and device development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organisations. Their headquarters are located in Dublin, Ireland.
Company Leadership MI
MC
UM
CI
Viva Biotech operates a leading structure-based, integrated drug discovery platform, providing structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their preclinical stage innovative drug development.
Company Leadership
XW
The International Rice Research Institute (IRRI) focuses on harnessing rice science to combat poverty and hunger through impactful partnerships and sustainable practices. Operating in 17 countries across Asia and Africa, IRRI develops regionally tailored research and innovative solutions to address food security and climate challenges. Their services include research support, digital innovations, and educational programs aimed at empowering stakeholders in the rice-based agri-food sector. With a commitment to improving livelihoods and nutrition, IRRI collaborates with various partners to drive advancements in rice science and agricultural planning.
Company Leadership NJ
AP
JP
The George Institute for Global Health is a health and medical research institute whose mission is to improve the health of millions of people worldwide. The company will achieve this by: 1) providing the best evidence to guide critical health decisions; 2) engaging with decision makers to enact real change; 3) targeting global epidemics, particularly of chronic diseases and injury; and 4) focusing on vulnerable populations in both rich and poor countries.
Company Leadership AP
SB
Frequently Asked Questions Regarding Pharmaron Top Executives and Leadership Team
